scholarly journals LBA26 Phase II study of the oral HIF-2α inhibitor MK-6482 for Von Hippel-Lindau (VHL) disease-associated clear cell renal cell carcinoma (ccRCC): Update on RCC and non-RCC disease

2020 ◽  
Vol 31 ◽  
pp. S1158 ◽  
Author(s):  
R. Srinivasan ◽  
F. Donskov ◽  
O. Iliopoulos ◽  
W.K. Rathmell ◽  
V.K. Narayan ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Clear Cell ◽  
Phase Ii Study ◽  
Cell Renal Cell Carcinoma ◽  
Von Hippel Lindau ◽  
Vhl Disease

Sunitinib in non-clear cell renal cell carcinoma (ncc-RCC): A phase II study

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 5112-5112 ◽  
Author(s):  
E. R. Plimack ◽  
E. Jonasch ◽  
B. N. Bekele ◽  
L. A. Smith ◽  
J. C. Araujo ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Clear Cell ◽  
Phase Ii Study ◽  
Cell Renal Cell Carcinoma

scholarly journals Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study

2018 ◽  
Vol 50 (2) ◽  
pp. 488-494 ◽  
Author(s):  
Ki Sun Jung ◽  
Su Jin Lee ◽  
Se Hoon Park ◽  
Jae-Lyun Lee ◽  
Se-Hoon Lee ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Clear Cell ◽  
Phase Ii Study ◽  
Open Label ◽  
Cell Renal Cell Carcinoma ◽  
Multicenter Phase

Presurgical bevacizumab in patients with metastatic clear cell renal cell carcinoma: A phase II study

2008 ◽  
Vol 26 (15_suppl) ◽  
pp. 5104-5104 ◽  
Author(s):  
E. Jonasch ◽  
C. G. Wood ◽  
S. Matin ◽  
P. Tamboli ◽  
K. Do ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Clear Cell ◽  
Phase Ii Study ◽  
Cell Renal Cell Carcinoma

scholarly journals Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma

2012 ◽  
Vol 23 (8) ◽  
pp. 2108-2114 ◽  
Author(s):  
J.-L. Lee ◽  
J.-H. Ahn ◽  
H.Y. Lim ◽  
S.H. Park ◽  
S.H. Lee ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Phase Ii ◽  
Renal Cell ◽  
Clear Cell ◽  
Phase Ii Study ◽  
Cell Renal Cell Carcinoma ◽  
Multicenter Phase

scholarly journals Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma

Oncogene ◽  
2016 ◽  
Vol 36 (8) ◽  
pp. 1080-1089 ◽  
Author(s):  
J M Thompson ◽  
Q H Nguyen ◽  
M Singh ◽  
M W Pavesic ◽  
I Nesterenko ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Clear Cell ◽  
Cell Renal Cell Carcinoma ◽  
Von Hippel Lindau ◽  
Synthetically Lethal
Sign in / Sign up

Export Citation Format

Share Document